Insider · CIK 0001747260
Minnie Baylor-Henry
Files at APYX (Apyx Medical Corp), LNTH (Lantheus Holdings, Inc.), SCPH (scPharmaceuticals Inc.). First filing -, latest -.
Minnie Baylor-Henry files SEC Form 4 as director at APYX (Apyx Medical Corp), and also at LNTH (Lantheus Holdings, Inc.), SCPH (scPharmaceuticals Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Minnie Baylor-Henry has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | APYX Apyx Medical Corp | AGrant or award Stock Option (Option to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 15, 2026 |
| May 14, 2026 | LNTH Lantheus Holdings, Inc. | AGrant or award Common Stock | +4,137 | $0.00 | $0 | 14,018 | May 18, 2026 |
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -30,000 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -19,750 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,300 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -6,124 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,248 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Jun 3, 2025 | SCPH scPharmaceuticals Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 5, 2025 |
| May 15, 2025 | APYX Apyx Medical Corp | AGrant or award Stock Option (Option to Buy)derivative | +59,000 | $0.00 | $0 | 59,000 | May 19, 2025 |
| May 14, 2025 | LNTH Lantheus Holdings, Inc. | AGrant or award Common Stock | +2,537 | $0.00 | $0 | 9,881 | May 16, 2025 |
| May 14, 2025 | LNTH Lantheus Holdings, Inc. | AGrant or award Stock Option (right to buy)derivative | +4,543 | $0.00 | $0 | 4,543 | May 16, 2025 |
| Jan 15, 2025 | APYX Apyx Medical Corp | AGrant or award Stock Option (Option to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jan 17, 2025 |
Questions about Minnie Baylor-Henry
Answered from the filings on this page, as of the latest one.
Is Minnie Baylor-Henry buying or selling?
Minnie Baylor-Henry has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Minnie Baylor-Henry's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Minnie Baylor-Henry has 0.
Where does Minnie Baylor-Henry file Form 4?
Minnie Baylor-Henry has filed Form 4 at APYX (Apyx Medical Corp); LNTH (Lantheus Holdings, Inc.); SCPH (scPharmaceuticals Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.